Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -8.48%7.11B | -7.30%4.81B | -7.17%2.48B | -0.09%10.12B | 1.65%7.77B | 3.67%5.19B | 4.55%2.67B | 1.12%10.13B | 0.89%7.64B | 2.45%5B |
| Operating revenue | -8.48%7.11B | -7.30%4.81B | -7.17%2.48B | -0.09%10.12B | 1.65%7.77B | 3.67%5.19B | 4.55%2.67B | 1.12%10.13B | 0.89%7.64B | 2.45%5B |
| Other operating revenue | ---- | -3.67%379.03M | ---- | -3.90%752.66M | ---- | -3.19%393.47M | ---- | 16.33%783.23M | ---- | 6.50%406.44M |
| Total operating cost | -9.44%6.74B | -7.89%4.58B | -7.86%2.34B | 0.00%9.69B | 1.97%7.45B | 3.78%4.97B | 4.78%2.54B | 0.89%9.69B | 0.73%7.3B | 2.26%4.79B |
| Operating cost | -8.78%5.02B | -8.43%3.37B | -6.39%1.76B | 0.31%7.15B | 1.99%5.5B | 4.21%3.68B | 4.90%1.88B | 0.31%7.13B | 0.80%5.4B | 2.14%3.53B |
| Operating tax surcharges | -2.19%40.18M | 0.67%27.31M | 10.92%13.53M | 13.02%53.84M | 12.33%41.08M | 4.82%27.12M | -2.41%12.2M | -6.50%47.64M | -5.04%36.57M | 8.29%25.88M |
| Operating expense | -9.53%1.56B | -3.60%1.1B | -11.10%526.39M | -0.96%2.28B | 0.63%1.73B | 1.15%1.14B | 3.31%592.09M | 3.33%2.31B | 1.20%1.72B | 3.38%1.13B |
| Administration expense | -21.02%91.2M | -21.73%58.45M | 0.65%33.26M | -3.79%143.87M | -0.26%115.47M | -2.70%74.68M | 1.93%33.04M | 1.95%149.55M | 0.65%115.78M | 2.19%76.75M |
| Financial expense | -53.04%28.5M | -56.61%19.69M | -61.57%9.92M | -0.03%55.93M | 53.13%60.69M | 79.28%45.39M | 51.62%25.83M | -15.14%55.95M | -18.92%39.63M | -25.38%25.32M |
| -Interest expense (Financial expense) | -25.49%24.95M | -23.55%17.12M | -24.21%8.76M | -10.73%45.53M | -12.76%33.48M | -12.13%22.39M | -11.35%11.56M | -18.56%51M | -18.61%38.38M | -16.20%25.48M |
| -Interest Income (Financial expense) | -7.27%-19M | -13.22%-12.31M | -143.15%-6.07M | 47.12%-21.89M | 43.05%-17.71M | 42.95%-10.88M | 40.99%-2.5M | -44.16%-41.39M | -38.73%-31.09M | -62.03%-19.06M |
| Research and development | --1.69M | --1.08M | --509.12K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Credit Impairment Loss | ---- | ---- | ---- | -139.17%-6.77M | ---- | ---- | ---- | -3,904.49%-2.83M | ---- | ---- |
| Other net revenue | -0.63%127.99M | 3.04%91.16M | -29.39%36.66M | -17.42%170.66M | -4.23%128.8M | 4.56%88.47M | 80.10%51.92M | 47.69%206.66M | 54.84%134.49M | 46.04%84.61M |
| Fair value change income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 406.09%1.19M | ---- | ---- |
| Invest income | 19.68%110.45M | 15.25%72.83M | -15.09%34.67M | -14.26%131.92M | -17.05%92.29M | -2.42%63.19M | 52.22%40.83M | 46.89%153.86M | 61.36%111.26M | 60.73%64.76M |
| -Including: Investment income associates | 28.67%110.45M | 22.69%72.83M | -9.33%34.67M | -17.81%120.82M | -19.49%85.84M | -3.57%59.36M | 51.09%38.24M | 52.01%147M | 70.05%106.62M | 71.24%61.56M |
| Asset deal income | -114.79%-665.26K | -71.11%728.55K | -94.26%52.93K | -106.99%-539.2K | 25.90%4.5M | 80.43%2.52M | 367.10%922.81K | 519.38%7.71M | 187.83%3.57M | 7.71%1.4M |
| Other revenue | -43.16%18.2M | -22.65%17.6M | -80.95%1.94M | -1.44%46.06M | 62.89%32.01M | 23.32%22.76M | 462.50%10.17M | 38.35%46.73M | -10.57%19.65M | 12.87%18.45M |
| Operating profit | 9.82%491.51M | 5.40%322.83M | -4.02%177.18M | -7.01%603.31M | -4.90%447.57M | 2.17%306.3M | 14.67%184.61M | 16.84%648.82M | 15.33%470.63M | 15.60%299.79M |
| Add:Non operating Income | 414.60%4.17M | 493.01%4.18M | 528.24%3.49M | -65.46%1.44M | -12.48%810.67K | 5.91%704.26K | 17.49%555.78K | 1.80%4.18M | -73.41%926.27K | 36.87%664.99K |
| Less:Non operating expense | 303.60%3.55M | 209.68%721.93K | 255.32%691.74K | -45.68%3.45M | -83.98%878.96K | -95.38%233.12K | -52.27%194.68K | 67.20%6.36M | 61.45%5.49M | 98.85%5.04M |
| Total profit | 9.97%492.13M | 6.36%326.28M | -2.70%179.98M | -7.01%601.3M | -3.98%447.5M | 3.84%306.77M | 14.84%184.97M | 16.39%646.64M | 14.19%466.07M | 14.82%295.41M |
| Less:Income tax cost | 90.41%109.46M | 13.13%45.49M | 8.24%23.38M | -6.30%80.17M | -2.42%57.49M | 4.10%40.21M | 7.14%21.6M | 22.35%85.55M | 15.55%58.91M | 12.14%38.62M |
| Net profit | -1.88%382.67M | 5.34%280.79M | -4.14%156.6M | -7.12%521.13M | -4.21%390.01M | 3.80%266.56M | 15.95%163.37M | 15.53%561.08M | 13.99%407.16M | 15.23%256.79M |
| Net profit from continuing operation | ---- | ---- | ---- | -7.12%521.13M | ---- | ---- | ---- | 15.53%561.08M | ---- | ---- |
| Less:Minority Profit | 15,344.65%15.06K | 134.57%6.93K | 110.43%867.58 | -23.00%-40.15K | -101.50%-98.79 | ---20.03K | ---8.32K | ---32.64K | --6.59K | ---- |
| Net profit of parent company owners | -1.89%382.65M | 5.33%280.78M | -4.15%156.6M | -7.12%521.17M | -4.21%390.01M | 3.81%266.58M | 15.95%163.38M | 15.53%561.12M | 13.99%407.15M | 15.23%256.79M |
| Earning per share | ||||||||||
| Basic earning per share | -3.45%0.28 | 5.00%0.21 | 0.00%0.12 | -7.32%0.38 | -3.33%0.29 | 5.26%0.2 | 20.00%0.12 | 13.89%0.41 | 15.38%0.3 | 18.75%0.19 |
| Diluted earning per share | -3.45%0.28 | 5.00%0.21 | 0.00%0.12 | -7.32%0.38 | -3.33%0.29 | 5.26%0.2 | 20.00%0.12 | 13.89%0.41 | 15.38%0.3 | 18.75%0.19 |
| Other composite income | ||||||||||
| Total composite income | -1.88%382.67M | 5.34%280.79M | -4.14%156.6M | -7.12%521.13M | -4.21%390.01M | 3.80%266.56M | 15.95%163.37M | 15.53%561.08M | 13.99%407.16M | 15.23%256.79M |
| Total composite income of parent company owners | -1.89%382.65M | 5.33%280.78M | -4.15%156.6M | -7.12%521.17M | -4.21%390.01M | 3.81%266.58M | 15.95%163.38M | 15.53%561.12M | 13.99%407.15M | 15.23%256.79M |
| Total composite income of minority owners | 15,344.65%15.06K | 134.57%6.93K | 110.43%867.58 | -23.00%-40.15K | -101.50%-98.79 | ---20.03K | ---8.32K | ---32.64K | --6.59K | ---- |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.